For research use only. Not for therapeutic Use.
Adrafinil(CAT: I004396) is a prodrug that metabolizes into modafinil, a compound known for its wakefulness-promoting properties. It primarily acts by modulating the levels of dopamine, norepinephrine, and histamine in the brain, enhancing alertness and reducing fatigue without causing hyperactivity. Adrafinil is of interest in neuropharmacology research, particularly for studying disorders such as narcolepsy, sleep apnea, and other conditions associated with excessive daytime sleepiness. Its mechanism also provides insights into cognitive enhancement and the regulation of arousal systems, making it a tool for exploring potential therapeutic strategies for sleep-wake cycle disorders and neurodegenerative conditions.
Catalog Number | I004396 |
CAS Number | 63547-13-7 |
Molecular Formula | C15H15NO3S |
Purity | ≥95% |
Target | Others |
Solubility | DMSO:35 mg/ml |
Storage | 3 years -20C powder |
IUPAC Name | 2-benzhydrylsulfinyl-N-hydroxyacetamide |
InChI | InChI=1S/C15H15NO3S/c17-14(16-18)11-20(19)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15,18H,11H2,(H,16,17) |
InChIKey | CGNMLOKEMNBUAI-UHFFFAOYSA-N |
SMILES | C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)NO |